Search Results - "Partridge, D.G."

Lessons from a large norovirus outbreak: impact of viral load, patient age and ward design on duration of symptoms and shedding and likelihood of transmission by Partridge, D.G, Evans, C.M, Raza, M, Kudesia, G, Parsons, H.K

“…Summary Background Hospital norovirus outbreaks cause significant financial and operational disruption which should be minimised by optimal handling of…”
Get full text

FP2.4 Predicting the duration of symptoms and likelihood of transmission of norovirus – A retrospective study of a large outbreak in a UK teaching hospital by Partridge, D.G, Raza, M, Parsons, H.K

Get full text

Increasing prevalence of human fascioliasis (and an association with khat usage) in Sheffield, UK: A clinical and epidemiological case series by Green, E.W, Partridge, D.G, Green, S.T, McKendrick, M.W

Get full text

Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study by Williams, E.J., Mair, L., de Silva, T.I., Green, D.J., House, P., Cawthron, K., Gillies, C., Wigfull, J., Parsons, H., Partridge, D.G.

“…It can be a diagnostic challenge to identify patients with coronavirus disease 2019 in whom antibiotics can be safely withheld. This study evaluated the…”
Get full text

Universal use of surgical masks is tolerated and prevents respiratory viral infection in stem cell transplant recipients by Partridge, D.G., Sori, A., Green, D.J., Simpson, R., Poller, B., Raza, M., Kaur, H., Jessop, H., Colton, B., Nield, A., Evans, C.M., Lee, A.

“…Prevention of respiratory viral infection in stem cell transplant patients is important due to its high risk of adverse outcome. This single-centre, mixed…”
Get full text

Factors affecting turnaround time of SARS-CoV-2 sequencing for inpatient infection prevention and control decision making: analysis of data from the COG-UK HOCI study by Colton, H., Parker, M.D., Stirrup, O., Blackstone, J., Loose, M., McClure, C.P., Roy, S., Williams, C., McLeod, J., Smith, D., Taha, Y., Zhang, P., Hsu, S.N., Kele, B., Harris, K., Mapp, F., Williams, R., Flowers, P., Breuer, J., Partridge, D.G., de Silva, T.I.

“…Barriers to rapid return of sequencing results can affect the utility of sequence data for infection prevention and control decisions. To undertake a…”
Get full text

Evaluating the cost implications of integrating SARS-CoV-2 genome sequencing for infection prevention and control investigation of nosocomial transmission within hospitals by Panca, M., Blackstone, J., Stirrup, O., Cutino-Moguel, M.-T., Thomson, E., Peters, C., Snell, L.B., Nebbia, G., Holmes, A., Chawla, A., Machin, N., Taha, Y., Mahungu, T., Saluja, T., de Silva, T.I., Saeed, K., Pope, C., Shin, G.Y., Williams, R., Darby, A., Smith, D.L., Loose, M., Robson, S.C., Laing, K., Partridge, D.G., Price, J.R., Breuer, J.

“…The COG-UK hospital-onset COVID-19 infection (HOCI) trial evaluated the impact of SARS-CoV-2 whole-genome sequencing (WGS) on acute infection, prevention, and…”
Get full text